Provided by Tiger Trade Technology Pte. Ltd.

Fulcrum Therapeutics

3.82
-0.0100-0.26%
Volume:543.00K
Turnover:2.07M
Market Cap:291.46M
PE:-3.16
High:3.86
Open:3.84
Low:3.78
Close:3.83
52wk High:15.74
52wk Low:2.83
Shares:76.30M
Float Shares:63.49M
Volume Ratio:0.19
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2104
EPS(LYR):-1.1819
ROE:-32.38%
ROA:-19.59%
PB:0.94
PE(LYR):-3.23

Loading ...

Fulcrum Therapeutics offers CEO cash retention payment of $370,040 tied to change in control

Reuters
·
Jun 12

Ratings Weekly|Meta, Microsoft, IBM, CoreWeave, Lululemon and More to Watch

Tiger Newspress
·
Jun 07

BUZZ-Fulcrum down after announcing restructuring, plans to cut 85% jobs

Reuters
·
Jun 05

Fulcrum Therapeutics Undertakes Major Restructuring, Explores Strategic Alternatives

TIPRANKS
·
Jun 05

Fulcrum Therapeutics to Cut Most of Staff After Ending Sickle-Cell-Drug Development

Dow Jones
·
Jun 05

Fulcrum Therapeutics - to Reduce Workforce by 85% From 57 to 9 Employees, Completion Expected Q2 2026 - SEC Filing

THOMSON REUTERS
·
Jun 05

Fulcrum Therapeutics - Approves Restructuring Plan After Discontinuing Pociredir for Sickle Cell Disease - SEC Filing

THOMSON REUTERS
·
Jun 05

Fulcrum Therapeutics - Expects Aggregate Restructuring Charges of About $4.2 Mln - SEC Filing

THOMSON REUTERS
·
Jun 05

Fulcrum Therapeutics cuts workforce 85% in restructuring plan

Reuters
·
Jun 05

What's Going On With Fulcrum Therapeutics Stock On Thursday?

Benzinga_recent_news
·
Jun 04

Analysts’ Top Healthcare Picks: Fulcrum Therapeutics (FULC), ADC Therapeutics (ADCT)

TIPRANKS
·
Jun 04

JPMorgan Downgrades Fulcrum Therapeutics to Underweight From Overweight

MT Newswires Live
·
Jun 03

Why Fulcrum Therapeutics (FULC) Is Down 53.6% After Ending Pociredir And Exploring Strategic Options

Simply Wall St.
·
Jun 03

Fulcrum Therapeutics Inc : JP Morgan Cuts to Underweight From Overweight

THOMSON REUTERS
·
Jun 03

Fulcrum Therapeutics downgraded to Underweight from Overweight at JPMorgan

TIPRANKS
·
Jun 03

Goldman suspends rating on Fulcrum Therapeutics

TIPRANKS
·
Jun 03

Top Midday Decliners

MT Newswires Live
·
Jun 03

Fulcrum Therapeutics Cut to Underweight From Overweight by Piper Sandler

Dow Jones
·
Jun 03

Nasdaq Biotech Index Slides 2.6% as Fulcrum Shares, Abivax Adrs Sink Following Their Trial Results

THOMSON REUTERS
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems

Reuters
·
Jun 02